MyFinsight
Home
About
Contact
cogt: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, COGT has $425,933K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
425,933
274,817
Total stockholders equity
302,464
155,036
Total liabilities and stockholders equity
425,933
274,817
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$6,354K
Short-term marketable
securities
$265,593K
Cash and cash
equivalents
$125,297K
Other assets
$4,488K
Restricted cash
$336K
Property and equipment,
net
$5,274K
Operating lease,
right-of-use assets
$18,591K
Total current assets
$397,244K
Total assets
$425,933K
Total liabilities and
stockholders equity
$425,933K
Total stockholders
equity
$302,464K
Total liabilities
$123,469K
Accumulated deficit
-$1,085,928K
Accumulated other
comprehensive income
$208K
Additional paid-in capital
$1,280,128K
Other liabilities
$2,370K
Operating lease
liabilities, net of current...
$14,603K
Long-term debt, net
$44,250K
Total current
liabilities
$62,246K
Common stock, 0.001 par
value 300,000,000...
$141K
Preferred stock,
value-Series BNon Voting...
$54,085K
Preferred stock,
value-Series ANon Voting...
$53,830K
Operating lease
liabilities
$1,706K
Accrued expenses and
other current...
$44,511K
Accounts payable
$16,029K
Subscribe for Financial Insights
Cogent Biosciences, Inc. (COGT)
Cogent Biosciences, Inc. (COGT)